Advertisement

Topics

Low-Dose Anti-Thymocyte Globulin Preserves Beta-Cell Function in New-onset Type 1 Diabetes

12:15 EDT 10 May 2019 | Medscape

Low-dose anti-thymocyte globulin (ATG) appears to preserve beta-cell function in patients with new-onset type 1 diabetes, researchers report.
Reuters Health Information

Original Article: Low-Dose Anti-Thymocyte Globulin Preserves Beta-Cell Function in New-onset Type 1 Diabetes

NEXT ARTICLE

More From BioPortfolio on "Low-Dose Anti-Thymocyte Globulin Preserves Beta-Cell Function in New-onset Type 1 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement